Target intelligence / Profile preview

Major capsid protein L1 (Human papillomavirus type 18) (HPV18 L1)

Target
HPV18 L1
Molecular classification
Viral protein, Structural protein, Other
01

Overview

The major capsid protein L1 from Human papillomavirus type 18 (HPV-18) is the primary structural component of the viral outer shell, which self-assembles into pentamers to form an icosahedral capsid. This protein plays a critical role in the viral life cycle by binding to heparan sulfate proteoglycans on the host cell surface, initiating viral attachment and subsequent entry via endocytosis. HPV-18 is a high-risk oncogenic virus strongly associated with cervical, anal, vulvar, vaginal, and oropharyngeal cancers. Recombinant HPV-18 L1 proteins are expressed to form non-infectious virus-like particles (VLPs) that serve as the key antigenic component in prophylactic vaccines, such as Gardasil, Gardasil 9, and Cervarix. These vaccines stimulate the host immune system to produce neutralizing antibodies against the L1 protein, thereby preventing viral infection and reducing the incidence of HPV-associated malignancies.

Other names
Human papillomavirus type 18 major capsid protein L1HPV-18 L1 capsid proteinHPV18 L1Major capsid protein L1L1 capsid proteinHPV-18 major capsid protein L1
02

Mechanism of action

Active immunization inducing neutralizing antibodies to prevent viral attachment and entry

03

Biological functions

Viral attachment to host cellViral entry into host cellEndocytosisCapsid assemblyImmune response
04

Disease associations

InfectionCancer
05

Safety considerations

Injection site reactions (pain, swelling, erythema)Systemic adverse events (fever, headache, fatigue, myalgia)SyncopeHypersensitivity reactionsLack of therapeutic efficacy in pre-existing infections
06

Interacting drugs

8 more in the full profile.

07

Biomarkers

Anti-HPV18 L1 antibody titerHPV-18 DNAHPV-18 L1 mRNA

Beyond the preview

Go deeper on Major capsid protein L1 (Human papillomavirus type 18) (HPV18 L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major capsid protein L1 (Human papillomavirus type 18) (HPV18 L1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call